|
Positie houder
|
Naam van de emittent
|
ISIN
|
Netto Shortpositie
|
Positiedatum
|
|
Millennium International Management LP
|
Alfen N.V.
|
NL0012817175
|
1.21
|
22 Feb 2024
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Alfen N.V.
|
NL0012817175
|
0.5
|
23 Feb 2024
|
|
Marshall Wace LLP
|
PostNL N.V.
|
NL0009739416
|
1.11
|
23 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
Alfen N.V.
|
NL0012817175
|
2.24
|
23 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
SBM Offshore N.V.
|
NL0000360618
|
0.51
|
23 Feb 2024
|
|
Voleon Capital Management LP
|
Alfen N.V.
|
NL0012817175
|
0.83
|
23 Feb 2024
|
|
Walleye Capital LLC
|
Alfen N.V.
|
NL0012817175
|
0.59
|
23 Feb 2024
|
|
Greenvale Capital LLP
|
Koninklijke Philips N.V.
|
NL0000009538
|
0.49
|
23 Feb 2024
|
|
JPMorgan Asset Management (UK) Ltd.
|
TomTom N.V.
|
NL0013332471
|
1.79
|
23 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
OCI N.V.
|
NL0010558797
|
0.97
|
26 Feb 2024
|
|
Adage Capital Management L.P.
|
Vivoryon Therapeutics N.V.
|
NL00150002Q7
|
0.74
|
26 Feb 2024
|
|
D. E. Shaw & Co., L.P.
|
AMG Critical Materials N.V.
|
NL0000888691
|
0.98
|
26 Feb 2024
|
|
Janus Henderson Investors UK Limited
|
Vivoryon Therapeutics N.V.
|
NL00150002Q7
|
2.8
|
26 Feb 2024
|
|
Marshall Wace LLP
|
AMG Critical Materials N.V.
|
NL0000888691
|
1.93
|
26 Feb 2024
|
|
Marshall Wace LLP
|
PostNL N.V.
|
NL0009739416
|
1.23
|
26 Feb 2024
|
|
Millennium International Management LP
|
Alfen N.V.
|
NL0012817175
|
1.3
|
26 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
Signify N.V.
|
NL0011821392
|
0.49
|
26 Feb 2024
|
|
Citadel Advisors LLC
|
Pharming Group N.V.
|
NL0010391025
|
1.0
|
27 Feb 2024
|
|
Janus Henderson Investors UK Limited
|
Vivoryon Therapeutics N.V.
|
NL00150002Q7
|
2.97
|
27 Feb 2024
|
|
AQR Capital Management, LLC
|
SBM Offshore N.V.
|
NL0000360618
|
0.49
|
27 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
PostNL N.V.
|
NL0009739416
|
0.66
|
27 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
Just Eat Takeaway.com N.V.
|
NL0012015705
|
2.1
|
27 Feb 2024
|
|
Marshall Wace LLP
|
AMG Critical Materials N.V.
|
NL0000888691
|
1.81
|
27 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
Alfen N.V.
|
NL0012817175
|
2.16
|
27 Feb 2024
|
|
Voleon Capital Management LP
|
Alfen N.V.
|
NL0012817175
|
0.94
|
28 Feb 2024
|
|
Voleon Capital Management LP
|
Just Eat Takeaway.com N.V.
|
NL0012015705
|
0.5
|
28 Feb 2024
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Alfen N.V.
|
NL0012817175
|
0.49
|
28 Feb 2024
|
|
Citadel Advisors LLC
|
Koninklijke Philips N.V.
|
NL0000009538
|
0.78
|
28 Feb 2024
|
|
AKO Capital LLP
|
Randstad N.V.
|
NL0000379121
|
1.0
|
28 Feb 2024
|
|
Marshall Wace LLP
|
AMG Critical Materials N.V.
|
NL0000888691
|
1.72
|
28 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
Alfen N.V.
|
NL0012817175
|
2.0
|
28 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
SBM Offshore N.V.
|
NL0000360618
|
0.46
|
29 Feb 2024
|
|
Voleon Capital Management LP
|
Just Eat Takeaway.com N.V.
|
NL0012015705
|
0.45
|
29 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
ING Groep N.V.
|
NL0011821202
|
0.41
|
29 Feb 2024
|
|
Qube Research & Technologies Ltd.
|
Alfen N.V.
|
NL0012817175
|
1.96
|
29 Feb 2024
|
|
PDT Partners, LLC
|
Alfen N.V.
|
NL0012817175
|
0.59
|
29 Feb 2024
|
|
Citadel Advisors LLC
|
Pharming Group N.V.
|
NL0010391025
|
1.13
|
29 Feb 2024
|
|
Adage Capital Management L.P.
|
Vivoryon Therapeutics N.V.
|
NL00150002Q7
|
0.87
|
29 Feb 2024
|
|
Marshall Wace LLP
|
ASR Nederland N.V.
|
NL0011872643
|
0.54
|
29 Feb 2024
|
|
Marshall Wace LLP
|
AMG Critical Materials N.V.
|
NL0000888691
|
1.67
|
29 Feb 2024
|
